Martelli A, Allavena A, Robbiano L, Mattioli F, Brambilla G
Institute of Pharmacology, University of Genova, Italy.
Pharmacol Toxicol. 1990 May;66(5):329-34. doi: 10.1111/j.1600-0773.1990.tb00758.x.
Metronidazole (MNZ), an antiprotozoan and antibacterial agent, has been shown to yield DNA-damaging reactive species after nitroreductive biotransformation. The genotoxic effect of MNZ was studied in primary cultures of both rat and human hepatocytes. In millimolar concentrations MNZ produced DNA fragmentation, as measured by the alkaline elution technique, and unscheduled DNA synthesis, as evaluated by quantitative autoradiography, in rat hepatocytes. The amount of DNA damage was directly related to the dose and the length of exposure, was increased by hypoxia and GSH depletion, and was markedly reduced by inhibition of cytochrome P-450 activity. In the same experimental conditions human hepatocytes resulted constantly more resistant than rat hepatocytes to the genotoxic activity of MNZ. These findings suggest that the rat hepatocyte model might be an inappropriate predictor of nitroimidazoles genotoxicity.
甲硝唑(MNZ)是一种抗原虫和抗菌剂,已证明在硝基还原生物转化后会产生具有DNA损伤作用的活性物质。在大鼠和人原代肝细胞培养物中研究了MNZ的遗传毒性作用。在毫摩尔浓度下,MNZ在大鼠肝细胞中产生了DNA片段化(通过碱性洗脱技术测定)以及DNA非预定合成(通过定量放射自显影评估)。DNA损伤的量与剂量和暴露时间直接相关,缺氧和谷胱甘肽耗竭会使其增加,而细胞色素P - 450活性的抑制则会使其显著降低。在相同实验条件下,人肝细胞对MNZ遗传毒性活性的抗性始终高于大鼠肝细胞。这些发现表明,大鼠肝细胞模型可能不是硝基咪唑类药物遗传毒性的合适预测指标。